United States· US:51316-207_4e0916a9-7c93-eb70-e063-6294a90a11b6
CVS Topical Analgesic Hemorrhoidal
A medicinal product containing dibucaine, registered in United States by CVS PHARMACY,INC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DIBUCAINE
- Manufacturer
- CVS PHARMACY,INC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11513162072828 mL in 1 TUBE (51316-207-28)
- ndc1151316-207-28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dibucaine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyCincainSmartpractice Europe Gmbh
- United KingdomNupercainal 1.1% ointmentBoston Healthcare Ltd
- BelgiumScheriproct 500 mg - 190 mgKaro Healthcare
- FinlandOrodropsOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Cincain, Doloposterine N Salbe
- Finland · Orodrops
- Greece · Otaset
- Italy · Cincocaina Cloridrato Allergeaze Smartpractice Europe
- Portugal · Nupercainal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/38847342-01bd-413b-8142-cbf2908e37c4 GET /v1/drugs/38847342-01bd-413b-8142-cbf2908e37c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "10",
"substance": "DIBUCAINE",
"productndc": "51316-207",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "M015",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about dibucaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.